Stereospecific interactions are necessary for Alzheimer disease amyloid-β toxicity
Stereospecific interactions are necessary for Alzheimer disease amyloid-β toxicity
复制标题
DOI:
10.1016/j.neurobiolaging.2009.02.018
复制
发表时间:
2011-02-01
影响因子:
4.2
通讯作者:
Cappai, Roberto
中科院分区:
文献类型:
--
作者:
Ciccotosto, Giuseppe D.;Tew, Deborah J.;Cappai, Roberto
Previous studies suggest membrane binding is a key determinant of amyloid beta (A beta) neurotoxicity. However, it is unclear whether this interaction is receptor driven. To address this issue, a D-handed enantiomer of A beta 42 (D-A beta 42) was synthesized and its biophysical and neurotoxic properties were compared to the wild-type A beta 42 (L-A beta 42). The results showed D- and L-A beta 42 are chemically equivalent with respect to copper binding, generation of reactive oxygen species and aggregation profiles. Cell binding studies show both peptides bound to cultured cortical neurons. However, only L-A beta 42 was neurotoxic and inhibited long term potentiation indicating L-A beta 42 requires a stereospecific target to mediate toxicity. We identified the lipid phosphatidylserine, as a potential target. Annexin V, which has very high affinity for externalized phosphatidylserine, significantly inhibited L-A beta 42 but not D-A beta 42 binding to the cultured cortical neurons and significantly rescued L-A beta 42 neurotoxicity. This suggests that All mediated toxicity in Alzheimer disease is dependent upon All binding to phosphatidylserine on neuronal cells. (C) 2009 Elsevier Inc. All rights reserved.